POLR2A and cancer: Whereas the proteasome-dependent degradation of the largest subunit of RNA polymerase II (RPB1), not XPB, contributes to the cell killing activity of triptolide, providing an insight to other targets and mechanisms that may exist for triptolide in cancer therapy (16).